TGFB1 and cancer: Pathways implicated in transcriptional regulation, TGF-β and Wnt signaling, acetylation, cancer related-pathways, angiogenesis, and cell differentiation were downregulated upon pembrolizumab treatment (−1.5 > Z-score < −0.5; Figure 5A).